MedTrace Logo

Screening Study to Identify Patients With Complement Factor I Deficiencies

NCT05072912 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 113

Last updated 2022-04-08

No results posted yet for this study

Summary

This is screening study to identify patients with Complement Factor I deficiencies. The primary objective is to identify participants with CFI deficiencies and assess the prevalence in the screened population.

Conditions

  • Previous Diagnosis With a Complement-mediated Disease and/or With Clinical Manifestations Reasonably Associated With Complement Factor I Deficiency

Sponsors & Collaborators

  • Catalyst Biosciences

    lead INDUSTRY

Eligibility

Min Age
6 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-21
Primary Completion
2021-11-23
Completion
2021-11-23

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05072912 on ClinicalTrials.gov